Gilead Stock Hits New 52-Week High (GILD)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Gilead (Nasdaq: GILD) hit a new 52-week high Tuesday as it is currently trading at $74.55, above its previous 52-week high of $74.34 with 3.7 million shares traded as of 10 a.m. ET. Average volume has been 7.1 million shares over the past 30 days.

Gilead has a market cap of $49.25 billion and is part of the health care sector and drugs industry. Shares are up 58.8% year to date as of the close of trading on Monday.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases worldwide. The company has a P/E ratio of 20.2, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Gilead as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, reasonable valuation levels, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Gilead Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!.

null

More from Markets

Don't Panic! The Risk of a Recession This Year Is Low

Don't Panic! The Risk of a Recession This Year Is Low

3 Simple Reasons to Buy Bank Stocks With Juicy Dividends

3 Simple Reasons to Buy Bank Stocks With Juicy Dividends

If Big Tech Companies Disappoint on Earnings, Expect a Stock-Selling Tsunami

If Big Tech Companies Disappoint on Earnings, Expect a Stock-Selling Tsunami

Papa John's Adopts 'Poison Pill' as Fallout from Schnatter's Resignation Spreads

Papa John's Adopts 'Poison Pill' as Fallout from Schnatter's Resignation Spreads

Oil Prices Spike as Trump Fires Angry Tweet Warning Iran of Grave 'Consequences'

Oil Prices Spike as Trump Fires Angry Tweet Warning Iran of Grave 'Consequences'